Amid new government directives around diversity, equity, and inclusion programs in the US, our April issue explores the pivots and adjustments pharma and healthcare interests are making to maintain the progress of such efforts in advancing clinical research.
Related Posts
Engaging Emerging Clinical Investigators Yields Unique Benefits for All
Benjamin Marcum, MD, family practitioner, Stephenville Medical and Surgical Clinic, Privia Health Emerging investigators play a vital role in bringing…
The Power of Simplicity for First-in-Human Studies
Image Credit: © Egor – stock.adobe.com Bringing a new treatment to market is a complex process with many moving parts.…
Moderna’s mRNA-1010 Flu Vaccine Meets Efficacy Goals in Phase III Trial of Adults 50+
Image Credit: © Dr_Microbe – stock.adobe.com Key takeaways Large-Scale, Multinational Trial Design: The P304 study enrolled over 40,000 participants across…